Epilepsy & Seizures
Conference Coverage
Encouraging results for new epilepsy drug
Seizure frequency was significantly reduced and the seizure-freedom rate was significantly improved among patients who received cenobamate.
Conference Coverage
Wearable device clears a first ‘milestone’ in seizure detection
Automatic seizure detection “is feasible across a broad spectrum of epileptic seizure types.”
Conference Coverage
New laser therapy shows promise in children with treatment-resistant epilepsy
Of nearly 150 children, more than half of those who received MRI-guided laser interstitial thermal therapy were seizure free at 1 year.
Conference Coverage
SUDEP may explain 3% of all sudden deaths in children
SUDEP is rare, “but not as rare as we thought it was.”
Conference Coverage
‘Worrisome’ rates of suicidal thoughts and behaviors in children with epilepsy
These findings highlight the need to screen all children with epilepsy for psychiatric disorders.
Literature Review
First guidelines for keto diets in adults with epilepsy released
Ketogenic diet therapies should only be undertaken with the support of medical professionals trained in their use.
Literature Review
Late-onset epilepsy tied to a threefold increased dementia risk
The findings support a bidirectional relationship between dementia and epilepsy.
Conference Coverage
Study supports halting antiseizure medications after neonatal seizures
A registry study found that halting antiseizure medications after acute symptomatic neonatal seizures had similar outcomes to maintenance therapy...
Conference Coverage
CBD for LGS: Fewer seizures, but thrombocytopenia risk
Cannabidiol reduces seizures in Lennox Gastaut syndrome out to 3 years, but has been linked to thrombocytopenia in children also on valproic acid...
News
FDA approves cannabidiol for tuberous sclerosis complex
The agency approved the drug for patients 1 year of age and older.